CONMED Corporation (CNMD) — Fair Value Analysis

Base-case fair value (P50): $55.04 · Current price: $50.41 · Verdict: Fairly Valued

The Verdict on CNMD

CONMED CORP (CNMD) is currently assessed as Fairly Valued based on our comprehensive Monte Carlo simulations. The stock's $50.41 is trading closely to our median fair value estimate (P50) of $55.04. This narrow differential implies a modest +9.2% from its current market position. Our probabilistic analysis, which evaluates thousands of forward-looking scenarios, indicates that CNMD is not significantly undervalued or overvalued. The market appears to be largely pricing in the company's expected performance and inherent risks, aligning its current trading price with its statistically derived intrinsic value.

How CNMD stacks up against peers

Our assessment of CONMED CORP (CNMD) positions the company with an "average" quality tier relative to its sector peers. This reflects its operational and financial health within its competitive landscape. This average quality profile is a critical component influencing our Monte Carlo simulations, directly shaping the projected range of future cash flows and, consequently, the derived median fair value of $55.04. While an average quality rating indicates a solid but not exceptional standing, it contributes to the Fairly Valued verdict. The current market price of $50.41 reflects this balanced outlook, suggesting the +9.2% represents a reasonable return expectation given the company's established operational characteristics.

What this means for investors

For investors evaluating CONMED CORP (CNMD), the "Fairly Valued" verdict suggests that the stock's $50.41 closely reflects its intrinsic worth, according to our robust probabilistic models. The modest +9.2% to our $55.04 estimate implies that any significant outperformance would likely hinge on the company exceeding its current operational expectations, which currently place its quality tier as average. Investors seeking substantial discrepancies between market price and fair value for deep-value opportunities might find CNMD less compelling for an immediate catalyst-driven play. FairCurve provides this detailed assessment to help guide investment decisions. To gain a deeper understanding of CNMD's full bear-case and bull-case distribution and track its fair value as new fundamentals are released, sign up for a free FairCurve account today.